Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TZP-102 in diabetic gastroparesis
NCT01664637Phase 2Terminated
- Sponsor
- Tranzyme Pharma
- Start
- Aug 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of TZP-102 in diabetic gastroparesis, sponsored by Tranzyme Pharma. Started Aug 2012; status: terminated.
02
Drugs
TZP-102
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT01664637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01664637.